Navigation Links
Chromium Picolinate Effective for Diabetes Care

A peer-reviewed analysis on chromium picolinate published in the current edition of Diabetes Technology & Therapeutics, confirmed that chromium picolinate is //effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes.

The review, which analyzed research on chromium picolinate, supports the consistent beneficial effects of chromium picolinate and refutes a previous review that analyzed efficacy after combining results from all types of supplemental chromium.

"The main messages are that all forms of chromium are not equivalent, and that higher doses of chromium picolinate are required for people with type 2 diabetes," said C. Leigh Broadhurst, PhD, Research Chemist, the lead author of the publication. "Previous chromium reviews examined all types of chromium at widely varying doses. But separating out chromium picolinate, which yields highly consistent results in research studies, compared to other chromium supplements shows that at doses between 200--1000 mcg it is a superior nutritional adjunct to diabetes treatments."

The review analyzed 15 clinical studies of people with diabetes. All studies showed chromium picolinate produced benefits in one or more standard measures of diabetes management, with no adverse events reported. The studies examined people with type 2, type 1, gestational and corticosteroid-induced diabetes. Although glycemic control varied by trial, all 15 trials showed improvements in one or more measurements of glycemic control, including fasting glucose, postprandial glucose, fasting insulin, postprandial insulin, glycated hemoglobin, or insulin sensitivity.

The authors concluded the greater bioavailability of chromium picolinate compared to other forms of chromium may explain its comparatively significant superior effects on glycemic and lipidemic control.

Supplemental chromium is available in several forms, including chromium picolinate, chro mium chloride, and chromium nicotinate.

Research indicates that chromium picolinate, the most studied form of chromium, has enhanced absorption and efficacy. A human clinical study conducted by Ohio State University Department of Nutrition and presented at the 2005 Federation of American Societies for Experimental Biology (FASEB) annual meeting showed that chromium picolinate is better absorbed than other commercially available forms of chromium.

Additionally, an animal study conducted at the U.S. Department of Agriculture and published in the Journal of the American College of Nutrition found that chromium picolinate was better absorbed by the tissues (e.g., liver and muscle) than chromium nicotinate and chromium chloride. Absorption into the tissue is important because for a mineral to be beneficial, it must survive the digestive tract and reach the bloodstream. Otherwise, minerals pass through the body, leaving it void of necessary nutrients.

About the Scientific Review

The studies reviewed in this paper were identified from a number of sources, such as PubMed, Science Direct, and a past review of chromium effects on glycemic control. A total of 1,690 subjects, including 1,505 receiving chromium picolinate, participated in these trials. Twelve of the 15 studies were randomized, controlled trials and three were open-label trials. Chromium picolinate dosages ranged from 200--1000 mcg chromium per day, and the duration of the supplementation ranged from one week to 10 months.

Chromium Picolinate for Diabetes

Chromium picolinate, which is sold in combination with the B-vitamin biotin under the brand name of Diachrome? for people with diabetes, is an essential trace mineral that helps to regulate insulin function. The chromium picolinate in Diachrome has been recognized as safe by many of the world's leading government and academic research institutions, including the U.S. Fo od and Drug Administration, the Institute of Medicine and the UK's Food Standards Agency.

In addition, biotin has been deemed safe by the U.S. Food and Drug Administration and is also Generally Recognized as Safe (GRAS) for use in foods and supplements.

Source-Eurekalert
SRI
'"/>




Related medicine news :

1. Chromium Exposure: Health Risk Of Workers Ignored
2. Is Chromium Treatment to Control Blood Sugar Effective?
3. Supplementation with Chromium Picolinate Improves Glycemic Control
4. Chromium May Help Diabetes, Cholesterol, and Heart Disease
5. Supplementation with Chromium Picolinate Improves Glycemic Control
6. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
7. Inhaled Steroids Safe & Effective for Children with Asthma
8. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
9. Fluoride Found Effective in Osteoporosis
10. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
11. Implantable Contact Lens Found Safe and Effective
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... ProVest Insurance Group, a family managed ... Raleigh regions, is organizing an extended charity drive to benefit the family of ... , After struggling since birth with several health challenges, T.J. was later diagnosed ...
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association ... standards of excellence for the field of eating disorders, announces the opening of ... 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. , ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
Breaking Medicine Technology: